Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.
Li Liu, Yichen Cao, Charles Chen, Xiaomei Zhang, Angela Mcnabola, D. Wilkie, S. Wilhelm, M. Lynch, Christopher A. Carter
Cancer Research